Shanghai Haohai Biological Files HKEX Return Disclosing Share Buyback
Shanghai Haohai Biological filed a next-day HKEX return disclosing a share buyback.
Related stories
X-FAB Silicon Foundries Reports Third-Quarter Revenue of $194.4 Million
M impact | EQUITY | Oct 29, 2026, 04:43 PM UTC
X-FAB Reports Q3 Revenue of USD 194.4 Million
M impact | EQUITY | Oct 29, 2026, 04:41 PM UTC
X-FAB Expects Q4 2026 Revenue Within Range
X-FAB expects Q4 2026 revenue within range, with an EBITDA margin within range.
M impact | EQUITY | Oct 29, 2026, 04:40 PM UTC
RBC Says Vertiv’s Strong Q3 Results Address Execution and Market-Share Concerns
RBC said Vertiv’s third-quarter results addressed investor concerns over execution risk and market share.
M impact | EQUITY | Oct 29, 2026, 04:40 PM UTC
X-FAB Reports Third-Quarter 2026 Results
M impact | EQUITY | Oct 29, 2026, 04:40 PM UTC
ServiceNow Shares Plunge More Than 25% on Slower Growth Outlook
ServiceNow shares fell more than 25% Thursday, putting them on track for their worst single-day performance in over 14 years, after the company gave a softer-than-expected outlook
M impact | EQUITY | Oct 29, 2026, 04:39 PM UTC